Skip to main content

Sanofi-Aventis S.A. ADR(SNY-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low51.88
Day High52.60
Open:52.57
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest News

Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool - Sat Jun 25, 9:23AM CDT
Motley Fool
Sat Jun 25, 9:23AM CDT
Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.
Why Sanofi May Be a Frontrunner in Endemic COVID-19
Motley Fool - Sat Jun 25, 7:09AM CDT
Motley Fool
Sat Jun 25, 7:09AM CDT
There is a promising outlook for its next generation of vaccines.
Why Regeneron Wasn't a Healthy Stock Today
Motley Fool - Thu Jun 2, 5:30PM CDT
Motley Fool
Thu Jun 2, 5:30PM CDT
The company is forking over $900 million in an upfront payment to fully own a cancer drug.

Latest Articles

Sanofi: No proof that vaccine linked to Philippines deaths
Sanofi rejects Philippine plea for refund on used vaccines